Evidence map›Paper›PMID 38328983›Full record

ReviewJournal of cutaneous pathology2024

Superficial acral calcified chondroid mesenchymal neoplasm harboring an FN1::FGFR2 fusion and review of the literature.

Isidro Machado, Vasileia Damaskou, Eleftherios Ioannidis, George Jour, Konstantinos Linos

Open access · bronzeAbstract readReviewCase Reports
In one paragraph

Review in Journal of cutaneous pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 3 countries.

Isidro MachadoDepartment of Pathology, Instituto Valenciano de Oncología, Patologika Laboratory Hospital Quirón-Salud, Valencia, Spain.ORCID https://orcid.org/0000-0001-7318-1330
Vasileia Damaskou2nd Department of Pathology, National and Kapodistrian University of Athens, School of Medicine, "Attikon" University Hospital, Athens, Greece.
Eleftherios Ioannidis"Total Skin Dermatology" Clinic, Athens, Greece.
George JourDepartment of Pathology and Dermatology, New York School of Medicine, New York, USA.
Konstantinos LinosDepartment of Pathology & Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.ORCID https://orcid.org/0000-0001-9462-652X
Athens Orthopedic Clinic · USMemorial Sloan Kettering Cancer Center · USNational and Kapodistrian University of Athens · GRSadick Dermatology · USUniversitat de València · ES

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Calcified chondroid mesenchymal neoplasm is a recently recognized bone and soft tissue entity primarily found in the extremities and the temporomandibular joint. This neoplasm is typically driven by the fusion of the FN1 gene with a kinase. In this case report, we provide a detailed account of a rare superficial calcified chondroid mesenchymal neoplasm located on the left big toe, characterized by an FN1::FGFR2 fusion. The tumor exhibited a peripheral collarette and consisted of large intradermal histiocytoid to epithelioid cells with no mitotic activity. These cells displayed fine chromatin and abundant pale eosinophilic cytoplasm, forming a swirling syncytium. They were interspersed with localized areas of glassy chondromyxoid matrix containing randomly mineralized calcific material and isolated osteoclast-like giant cells. RNA sequencing confirmed the presence of an FN1 (exon 29)::FGFR2 (exon 7) gene fusion. Our report emphasizes the importance for dermatopathologists to consider this entity when evaluating superficial lesions displaying mesenchymal, chondroid, and calcified attributes.

Indexed as

Soft Tissue NeoplasmsEpithelioid CellsExonsFibronectinsGene FusionGiant CellsHumansReceptor, Fibroblast Growth Factor, Type 2FGFR2 protein, humanFibronectinsFN1 protein, humanReceptor, Fibroblast Growth Factor, Type 2acralcalcified chondroid mesenchymal neoplasmFGFR2FN1superficial

Identifiers

PMID38328983
PMCPMC11001517
OpenAlexW4391652468

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.